Arch Therapeutics, Inc.

Published: July 19, 2017, 8 p.m.

b'

Interested in a new biotechnology product that can help improve the speed of wound care, surgical care, and intervention care?\\xa0Terrence Norchi, President & CEO of Arch Therapeutics, Inc. (OTCQB: ARTH) explains how the company is developing novel approaches as a medical device company to help in patient treatment.

'